Accreditation

Upon completion of these educational activities,
participants will be able to:

  1. Describe the burden of illness in patients with atopic dermatitis.
  2. Identify barriers to the optimal treatment of patients with atopic dermatitis.
  3. Manage patients with atopic dermatitis in accordance with clinical guidelines and expert recommendations.
  4. Summarize research on the safety, efficacy, and mechanisms of action of emerging therapies for the treatment of atopic dermatitis.
  5. Apply knowledge of the pathophysiology of atopic dermatitis to the selection of treatments.

Module 1: 
Burden of Illness and Barriers of Optimal Treatment in AD

CME Credit: .50

In this module, you will gain insight into the burden of illness in patients with Atopic Dermatitis. Additionally, Dr. Brar will identify barriers to the optimal treatment plan for AD patients.

Module 2:  Evolution in Our Understanding of Atopic Dermatitis and Emerging Therapies

CME Credit: 1.0

In this module, Dr. Boguniewicz will present research on the safety, efficacy, and mechanisms of action of emerging therapies for the treatment of atopic dermatitis, including how to integrate the pathophysiology of AD into the selection of treatments.

Module 3: Roundtable: Applying Emerging Clinical Research and Treatments to Everyday Clinical Practice

CME Credit: 1.0
Nursing Contact Hours:  1.2

In this module, expert faculty participate in a roundtable discussion about the effective management of patients with atopic dermatitis in accordance with clinical guidelines and expert recommendations, and how to apply knowledge of the pathophysiology of AD to the selection of treatments.

Target Audience

This activity has been designed to meet the educational needs of primary care physicians, nurse practitioners, dermatologists and allergists as well as allied health professionals who treat patients with AD.

Accreditation Statement

National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

National Jewish Health designates these courses with the following credit totals.

  • Module 1:  .5 AMA PRA Category 1 Credits
  • Module 2:  1.0 AMA PRA Category 1 Credits
  • Module 3:  1.0 AMA PRA Category 1 Credits™ and 1.2 nursing contact hours.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Program Support

This activity is supported by an independent educational grant from Pfizer, Inc.

Requirements for Successful Completion

In order to receive credit, participants must complete the pre-test, view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test with a passing score of ≥ 75%, and evaluation form.

Faculty & Disclosure Information

In accordance with ACCME requirements, National Jewish Health has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.

Dr. Mark Boguniewicz

Professor
Division of Pediatric Allergy and Clinical Immunology
Department of Pediatrics
National Jewish Health, Denver, CO
Dr. Boguniewicz declares that he is an Advisory Board Member of Celgene, Regeneron and Sanofi Genzyme.  Also, he is an Investigator for Regeneron.

Dr. Bruce Lanser

Assistant Professor
Director, Pediatric Food Allergy Program
Associate Director, Pediatric Allergy Fellowship Program
Division of Allergy & Clinical Immunology
National Jewish Health, Denver, CO
Dr. Lanser declares that he is an Advisory Board Member of AImmune, a Speaker for Mylan and and Investigator for AImmune and DBV.

Noreen Heer Nicol, PhD, RN, FNP

Associate Professor
University of Colorado, College of Nursing
Dr. Nicol declares that she is an Advisory Board Member for the Dermatology Nurses Association and the National Eczema Association.  Also, she is a Speaker for the Dermatology Nurses Association and the National Association of Pediatric Nurse Practitioners.

Jennifer Moyer Darr, LCSW

Manager – Outpatient Behavioral Health
National Jewish Health, Denver, CO
Ms. Moyer Darr declares that she is a Speaker for the Allergy and Anaphylaxis Network and the National Eczema Association.

Elizabeth Swanson, MD

Rocky Mountain Hospital for Children
Assistant Professor
University of Colorado School of Medicine
Dr. Swanson declares that she is an Advisory Board Member for Allergan, Amgen and Sanofi Regeneron.  Also, she is a Speaker for Aqua, Bayer and Valeant.

Faculty Reviewers

Dr. Harold Nelson
Professor of Medicine
National Jewish Health, Denver, CO
Dr. Nelson declares that he is a Consultant for Merck and an Investigator for Circassia.

Dr. Ronina Covar
Associate Professor of Medicine
National Jewish Health, Denver, CO
Dr. Covar declares that she is an Advisory Board Member for Novartis/Genentech, a Consultant for GlaxoSmithKline and Novartis Genentech and an Investigator for AstraZeneca and Roche.

Planners

Andrea Harshman, MHA, CHCP, CMP-HC
Director
Office of Professional Education
National Jewish Health, Denver, CO
Ms. Harshman has no financial interests/relationships or affiliations in relation to this activity.

Matthew Stern
Medical Education Project Specialist
Office of Professional Education
National Jewish Health, Denver, CO
Mr. Stern has no financial interests/relationships or affiliations in relation to this activity.

CME Disclaimer

National Jewish Health (”NJH”) and its officers, Board of Directors, faculty, employees, representatives, and other agents (collectively, “NJH Parties”) shall not be responsible in any capacity for, and do not warrant any content whatsoever, in any NJH publication or other product (in any medium), or the use or reliance on any such content, and expressly disclaim any and all liability for such content. All such responsibility for content and use of product solely rests with the authors or the advertisers, as the case may be.

By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from, any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any NJH live meeting, publication, online course or other product.

Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of the NJH Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.

Hardware/Software Requirements

To access these activities, users will need:

A computer with an Internet connection, Adobe Flash Player and/or an HTML5 capable browser for video playback

Internet Explorer 10+
Firefox 8+
Safari 6+
or any other W3C standards
compliant browser

Adobe Acrobat Reader

We recommend a device that has a display capability of 1024 x 768 or better
Mobile devices are okay for this activity but to get the best experience a tablet device or larger is recommended.

Contact Information

For questions regarding this activity, please contact the Office of Professional Education at National Jewish Health:
303.398.1000 or proed@njhealth.org.